Back to Agenda
Enabling Innovation and Regulatory Agility to Address Sustainability, Environment, and Climate Goals
Session Chair(s)
Ana Padua, MSc, RPh
Director EU Global Regulatory and Scientific Policy
EMD Serono, Switzerland
This session will include the regulator and industry perspective on the Green Deal initiative and chemical agenda and will have discussions on identified case study areas of expected heavy impact where panelists from industry, SMEs, and regulators will come together to share concerns and discuss opportunities and solutions on how to manage a more sustainable and environmentally future – for example through regulatory tools which enable innovation to address the challenges.
Learning Objective : Identify insights into how manufacturers and regulators can collaborate to deliver a revolution without risks to the supply of medicines.
Speaker(s)
EMA Update Enabling Innovation and Regulatory Agility to Address Sustainability, Environment, and Climate Goals
Veronika Jekerle, PhD, RPh
European Medicines Agency, Netherlands
Head of Pharmaceutical Quality
Sustainability and CMC (Chemistry, Manufacturing and Controls)
Benjamin Stevens, PhD, MPH
GlaxoSmithKline, United States
Director CMC Policy and Advocacy
Managing Low Risk Post Approval Changes (PAC) in the PQS Only for Companies Demonstrating an Effective PQS
Anders Vinther, PhD, MSc
QBA Leaders, United States
Founder and Chief Executive Officer
Have an account?